{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T11:58:14Z","timestamp":1788263894092,"version":"build-2803163510"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Pituitary Research Society, a non-profit organization"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.clineuro.2020.105865","type":"journal-article","created":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T03:07:05Z","timestamp":1587524825000},"page":"105865","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Somatostatin receptor profile in pituitary thyrotroph adenomas"],"prefix":"10.1016","volume":"195","author":[{"given":"Eleni","family":"Thodou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4281-8196","authenticated-orcid":false,"given":"George","family":"Kontogeorgos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clineuro.2020.105865_bib0005","series-title":"Thyrotropin-Secreting Pituitary Adenomas. 2019 Jan 11","author":"Beck-Peccoz","year":"2000"},{"key":"10.1016\/j.clineuro.2020.105865_bib0010","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s12022-009-9094-y","article-title":"Clinicopathological characterization of TSH-producing adenomas: special reference to TSH-immunoreactive but clinically non-functioning adenomas","volume":"20","author":"Wang","year":"2009","journal-title":"Endocr. Pathol."},{"key":"10.1016\/j.clineuro.2020.105865_bib0015","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJM198312153092406","volume":"309","author":"Reichlin","year":"1983","journal-title":"Engl. J. Med."},{"key":"10.1016\/j.clineuro.2020.105865_bib0020","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1006\/frne.1999.0183","article-title":"Somatostatin and its receptor family","volume":"20","author":"Patel","year":"1999","journal-title":"Front. Neuroendocrinol."},{"issue":"Suppl 1","key":"10.1016\/j.clineuro.2020.105865_bib0025","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10555-011-9293-0","article-title":"Somatostatin analogs for the treatment of neuroendocrine tumors","volume":"30","author":"Culler","year":"2011","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.clineuro.2020.105865_bib0030","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1023\/A:1020764013137","article-title":"G. Piaditis, Composite somatotroph-ACTH-immunoreactive pituitary adenoma with transformation of hyperplasia to adenoma","volume":"4","author":"Mazarakis","year":"2001","journal-title":"Pituitary"},{"key":"10.1016\/j.clineuro.2020.105865_bib0035","first-page":"2047","article-title":"Immunocytochemical detection of somatostatin receptors sst1, sstr2A, sstr2B and sstr3 in paraffin-embedded breast cancer tissue using subtype-specific antibodies","volume":"4","author":"Schultz","year":"1998","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.clineuro.2020.105865_bib0040","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1136\/jcp.2005.026914","article-title":"Mapping of somatostatin receptor types in GH or\/and PRL- producing pituitary adenomas","volume":"59","author":"Thodou","year":"2006","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.clineuro.2020.105865_bib0045","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1126\/science.179.4068.77","article-title":"Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone","volume":"179","author":"Brazeau","year":"1973","journal-title":"Science"},{"key":"10.1016\/j.clineuro.2020.105865_bib0050","doi-asserted-by":"crossref","first-page":"R223","DOI":"10.1530\/JME-14-0011","article-title":"Somatostatin receptor ligands and resistance to treatment in pituitary adenomas","volume":"52","author":"Cuevas-Ramos","year":"2014","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.clineuro.2020.105865_bib0055","first-page":"3455","article-title":"Expression and localization of somatostatin receptor SSTR1, SSTR2, and SSTR3 messenger RNAs in primary human tumors using in situ hybridization","volume":"154","author":"Reubi","year":"1994","journal-title":"Cancer Res."},{"key":"10.1016\/j.clineuro.2020.105865_bib0060","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1210\/er.2002-0007","article-title":"Peptide receptors as molecular targets for cancer diagnosis and therapy","volume":"24","author":"Reubi","year":"2003","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.clineuro.2020.105865_bib0065","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1159\/000079048","article-title":"Molecular pathology of the pituitary","volume":"32","author":"Hofland","year":"2004","journal-title":"Front. Horm. Res."},{"key":"10.1016\/j.clineuro.2020.105865_bib0070","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1530\/eje.0.1330686","article-title":"In vivo responsiveness of morphological variants of growth hormone-producing pituitary adenomas to octreotide","volume":"133","author":"Ezzat","year":"1995","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.clineuro.2020.105865_bib0075","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1507\/endocrj.K06-177","article-title":"Somatostatin receptor subtypes mRNA in TSH-secreting pituitary adenomas: a case showing a dramatic reduction in tumor size during short octreotide treatment","volume":"54","author":"Horiguchi","year":"2007","journal-title":"Endocr. J."},{"key":"10.1016\/j.clineuro.2020.105865_bib0080","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1507\/endocrj.K06-133","article-title":"Expression of type 5 somatostatin receptor in TSH-secreting pituitary adenomas: a possible marker for predicting long-term response to octreotide therapy","volume":"54","author":"Yoshihara","year":"2007","journal-title":"Endocr. J."},{"key":"10.1016\/j.clineuro.2020.105865_bib0085","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s11102-010-0271-2","article-title":"In vivo and in vitro response to octreotide LAR in a TSH-secreting adenoma: characterization of somatostatin receptor expression and role of subtype 5","volume":"14","author":"Gatto","year":"2011","journal-title":"Pituitary"},{"key":"10.1016\/j.clineuro.2020.105865_bib0090","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1089\/thy.2015.0041","article-title":"Primary Medical treatment of thyrotropin-secreting pituitary adenomas by first-generation somatostatin analogs: a case study of seven patients","volume":"25","author":"Rimareix","year":"2015","journal-title":"Thyroid"},{"key":"10.1016\/j.clineuro.2020.105865_bib0095","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/cen.13431","article-title":"Treatment of a thyrotropin-secreting pituitary adenoma (TSH-oma) with pasireotide LAR","volume":"87","author":"van Eersel","year":"2017","journal-title":"Clin. Endocrinol. (Oxf)."},{"issue":"Suppl 1","key":"10.1016\/j.clineuro.2020.105865_bib0100","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000080741","article-title":"Functional activity of the multiligand analog SOM230 at human recombinant somatostatin receptor subtypes supports its usefulness in neuroendocrine tumors","volume":"80","author":"Schmid","year":"2004","journal-title":"Neuroendocrinol."},{"key":"10.1016\/j.clineuro.2020.105865_bib0105","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1365-2265.2011.04200.x","article-title":"Balance between somatostatin and D2 receptor expression drives TSH-secreting adenoma response to somatostatin analogues and dopastatins","volume":"76","author":"Gatto","year":"2012","journal-title":"Clin. Endocrinol. (Oxf)."},{"issue":"June 20","key":"10.1016\/j.clineuro.2020.105865_bib0110","doi-asserted-by":"crossref","first-page":"E3049","DOI":"10.3390\/ijms20123049","article-title":"Somatostatin Analogues in the treatment of neuroendocrine tumors: past, present and future","author":"Stueven","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.clineuro.2020.105865_bib0115","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/PAS.0b013e31823d07f3","article-title":"Somatostatin receptor subtype 2a immunohistochemistry using a new monoclonal antibody selects tumors suitable for in vivo somatostatin receptor targeting","volume":"36","author":"K\u00f6rner","year":"2012","journal-title":"Am. J. Surg. Pathol."}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846720302080?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846720302080?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T14:33:12Z","timestamp":1759588392000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846720302080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":23,"alternative-id":["S0303846720302080"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2020.105865","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Somatostatin receptor profile in pituitary thyrotroph adenomas","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2020.105865","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105865"}}